Physicians and scientists from the UCLA Health Jonsson Comprehensive Cancer Center will present new research at the American Association for Cancer Research (AACR) Annual Meeting, highlighting ...
Morning Overview on MSN
Experimental Alzheimer’s approach reverses cognitive decline in mice
Researchers have reversed cognitive decline in mice engineered to mimic Alzheimer’s disease, using nanoparticles that repair ...
A precision cancer strategy that selectively kills tumour cells while leaving healthy tissue intact may be within reach for the majority of colorectal cancer patients, according to new research ...
The etiology of liver cirrhosis has transformed from hepatitis B virus-driven to metabolic dysfunction-associated steatotic liver disease (MASLD). In ...
Researchers have identified a novel therapeutic approach for colorectal cancer by exploiting a specific genetic vulnerability found in a majority of patients. The study focuses on the adenomatous ...
Integrating proteomics with systems biology reveals complex cellular networks, improving disease mechanisms understanding and precision medicine applications.
The big pharma and AI drug developer expand on a partnership that launched with a 2023 software licensing accord.
Researchers have identified a novel therapeutic approach for colorectal cancer by exploiting a specific genetic vulnerability ...
A precision cancer strategy that selectively kills tumour cells while leaving healthy tissue intact may be within reach for ...
The findings suggest that APC-deficient cells rely on ALDH2 to manage metabolic stress, making them particularly vulnerable when this pathway is disrupted. In contrast, cells with intact APC function ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results